2025
SJR Q1
JCR Q2 · 3,6
161 matched articles
SCIE
Journal detail
Basic and Clinical Pharmacology and Toxicology
- Publisher
- Wiley-Blackwell
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1742783517427843
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,978
- Quartile Q1
- H-Index 113
- Cites/doc 3,7
- Docs (3y) 377
- Cites (3y) 1.433
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,6
- 5Y JIF 3,4
- JCI 0,83
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
- Pharmacology Q2
- Toxicology Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,978 | 3,6 | 3,4 | 0,83 | Q2 | 113 |
| 2024 | Q2 | Q2 | 0,822 | 3,3 | 3,3 | 0,78 | Q2 | 108 |
| 2023 | Q2 | Q2 | 0,744 | 2,7 | 3,2 | 0,61 | Q3 | 108 |
| 2022 | Q2 | Q2 | 0,681 | 3,1 | 3,2 | 0,62 | Q3 | 108 |
| 2021 | Q2 | Q2 | 0,745 | 3,7 | 3,4 | 0,74 | Q2 | 108 |
| 2020 | Q2 | Q2 | 0,805 | 4,1 | 3,5 | 0,87 | Q2 | 108 |
| 2019 | Q2 | Q3 | 0,714 | 2,7 | 2,7 | 0,85 | Q2 | 108 |
| 2018 | — | Q3 | — | 2,5 | 2,6 | 0,84 | Q2 | — |
| 2017 | Q2 | Q2 | 0,655 | 2,7 | 2,7 | 0,9 | Q2 | 108 |
| 2016 | Q2 | Q2 | 0,573 | 3,2 | 2,7 | — | — | 108 |
| 2015 | Q2 | Q2 | 0,533 | 3,1 | 2,6 | — | — | 108 |
| 2014 | Q2 | Q2 | 0,747 | 2,4 | 2,3 | — | — | 108 |
| 2013 | Q2 | Q2 | 0,756 | 2,3 | 2,5 | — | — | 108 |
| 2012 | Q2 | Q3 | 0,691 | 2,1 | 2,4 | — | — | 108 |
| 2011 | Q1 | Q2 | 0,802 | 2,2 | 2,3 | — | — | 108 |
| 2010 | Q2 | Q2 | 0,724 | 2,4 | 2,3 | — | — | 108 |
| 2009 | — | Q2 | — | 2,3 | 2,3 | — | — | — |
| 2008 | — | Q3 | — | 2,1 | 2,1 | — | — | — |
| 2007 | — | Q3 | — | 1,8 | 2 | — | — | — |
| 2006 | — | Q3 | — | 1,8 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 128/356 |
| 2025 | TOXICOLOGY | SCIE | Q2 | Q2 | 35/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 122/352 |
| 2024 | TOXICOLOGY | SCIE | Q2 | Q2 | 37/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 167/354 |
| 2023 | TOXICOLOGY | SCIE | Q3 | Q3 | 56/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 152/278 |
| 2022 | TOXICOLOGY | SCIE | Q2 | Q3 | 46/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 134/279 |
| 2021 | TOXICOLOGY | SCIE | Q2 | Q2 | 41/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 103/276 |
| 2020 | TOXICOLOGY | SCIE | Q2 | Q2 | 33/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 143/271 |
| 2019 | TOXICOLOGY | SCIE | Q3 | Q2 | 50/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 142/267 |
| 2018 | TOXICOLOGY | SCIE | Q3 | Q2 | 53/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 120/261 |
| 2017 | TOXICOLOGY | SCIE | Q2 | Q2 | 43/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/257 |
| 2016 | TOXICOLOGY | SCIE | Q2 | — | 25/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 72/255 |
| 2015 | TOXICOLOGY | SCIE | Q2 | — | 24/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 124/255 |
| 2014 | TOXICOLOGY | SCIE | Q2 | — | 44/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 125/256 |
| 2013 | TOXICOLOGY | SCIE | Q3 | — | 47/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/261 |
| 2012 | TOXICOLOGY | SCIE | Q3 | — | 51/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 127/261 |
| 2011 | TOXICOLOGY | SCIE | Q3 | — | 47/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 124/252 |
| 2010 | TOXICOLOGY | SCIE | Q2 | — | 37/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 121/237 |
| 2009 | TOXICOLOGY | SCIE | Q2 | — | 36/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 127/219 |
| 2008 | TOXICOLOGY | SCIE | Q3 | — | 42/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 120/205 |
| 2007 | TOXICOLOGY | SCIE | Q3 | — | 42/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/199 |
| 2006 | TOXICOLOGY | SCIE | Q3 | — | 41/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 119/193 |
| 2005 | TOXICOLOGY | SCIE | Q3 | — | 48/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | — | — | — |
| 2004 | TOXICOLOGY | SCIE | — | — | — |